Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT

Richard L. Baron, James H. Oliver, Gerald D. Dodd, Michael Nalesnik, Brenda L. Holbert, Brian Carr

Research output: Contribution to journalArticle

350 Citations (Scopus)

Abstract

PURPOSE: To evaluate the added value of hepatic arterial-dominant phase (HAP) imaging to portal venous-dominant phase (PVP) imaging in patients with hepatocellular carcinoma (HCC) at computed tomography (CT). MATERIALS AND METHODS: Sixty-six patients with proved HCC underwent biphasic contrast- enhanced CT. HAP and PVP images were obtained at 20-50 and 60-100 seconds, respectively. PVP images were evaluated for the number of HCC foci. Then, HAP images were reviewed to determine whether any additional HCCs were seen. RESULTS: Three hundred twenty-six tumor loci were seen. HAP images depicted 309 foci (95%) and PVP images 268 (82%). In seven patients (11%), tumor was visible only on HAP images. During the HAP, tumors were hyperattenuating compared with liver in 26 patients, of mixed attenuation in 26, and hypoattenuating in 14 without correlation with histologic appearance. Portal vein thrombosis was identified in 17 of 21 patients on HAP images; in 12 patients, the thrombosis was diagnosed as malignant with neovascularity within the thrombus or diffuse thrombus enhancement. CONCLUSION: Use of both HAP and PVP contrast-enhanced CT optimizes the evaluation of patients with or at risk for HCC.

Original languageEnglish
Pages (from-to)505-511
Number of pages7
JournalRadiology
Volume199
Issue number2
Publication statusPublished - May 1996

Fingerprint

Spiral Computed Tomography
Hepatocellular Carcinoma
Liver
Thrombosis
Tomography
Neoplasms
Portal Vein

Keywords

  • Computed tomography (CT), helical
  • Liver neoplasms
  • Liver, CT

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Baron, R. L., Oliver, J. H., Dodd, G. D., Nalesnik, M., Holbert, B. L., & Carr, B. (1996). Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT. Radiology, 199(2), 505-511.

Hepatocellular carcinoma : Evaluation with biphasic, contrast-enhanced, helical CT. / Baron, Richard L.; Oliver, James H.; Dodd, Gerald D.; Nalesnik, Michael; Holbert, Brenda L.; Carr, Brian.

In: Radiology, Vol. 199, No. 2, 05.1996, p. 505-511.

Research output: Contribution to journalArticle

Baron, RL, Oliver, JH, Dodd, GD, Nalesnik, M, Holbert, BL & Carr, B 1996, 'Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT', Radiology, vol. 199, no. 2, pp. 505-511.
Baron RL, Oliver JH, Dodd GD, Nalesnik M, Holbert BL, Carr B. Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT. Radiology. 1996 May;199(2):505-511.
Baron, Richard L. ; Oliver, James H. ; Dodd, Gerald D. ; Nalesnik, Michael ; Holbert, Brenda L. ; Carr, Brian. / Hepatocellular carcinoma : Evaluation with biphasic, contrast-enhanced, helical CT. In: Radiology. 1996 ; Vol. 199, No. 2. pp. 505-511.
@article{738a7543ca5d4df590c7a3fe8e71169d,
title = "Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT",
abstract = "PURPOSE: To evaluate the added value of hepatic arterial-dominant phase (HAP) imaging to portal venous-dominant phase (PVP) imaging in patients with hepatocellular carcinoma (HCC) at computed tomography (CT). MATERIALS AND METHODS: Sixty-six patients with proved HCC underwent biphasic contrast- enhanced CT. HAP and PVP images were obtained at 20-50 and 60-100 seconds, respectively. PVP images were evaluated for the number of HCC foci. Then, HAP images were reviewed to determine whether any additional HCCs were seen. RESULTS: Three hundred twenty-six tumor loci were seen. HAP images depicted 309 foci (95{\%}) and PVP images 268 (82{\%}). In seven patients (11{\%}), tumor was visible only on HAP images. During the HAP, tumors were hyperattenuating compared with liver in 26 patients, of mixed attenuation in 26, and hypoattenuating in 14 without correlation with histologic appearance. Portal vein thrombosis was identified in 17 of 21 patients on HAP images; in 12 patients, the thrombosis was diagnosed as malignant with neovascularity within the thrombus or diffuse thrombus enhancement. CONCLUSION: Use of both HAP and PVP contrast-enhanced CT optimizes the evaluation of patients with or at risk for HCC.",
keywords = "Computed tomography (CT), helical, Liver neoplasms, Liver, CT",
author = "Baron, {Richard L.} and Oliver, {James H.} and Dodd, {Gerald D.} and Michael Nalesnik and Holbert, {Brenda L.} and Brian Carr",
year = "1996",
month = "5",
language = "English",
volume = "199",
pages = "505--511",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",

}

TY - JOUR

T1 - Hepatocellular carcinoma

T2 - Evaluation with biphasic, contrast-enhanced, helical CT

AU - Baron, Richard L.

AU - Oliver, James H.

AU - Dodd, Gerald D.

AU - Nalesnik, Michael

AU - Holbert, Brenda L.

AU - Carr, Brian

PY - 1996/5

Y1 - 1996/5

N2 - PURPOSE: To evaluate the added value of hepatic arterial-dominant phase (HAP) imaging to portal venous-dominant phase (PVP) imaging in patients with hepatocellular carcinoma (HCC) at computed tomography (CT). MATERIALS AND METHODS: Sixty-six patients with proved HCC underwent biphasic contrast- enhanced CT. HAP and PVP images were obtained at 20-50 and 60-100 seconds, respectively. PVP images were evaluated for the number of HCC foci. Then, HAP images were reviewed to determine whether any additional HCCs were seen. RESULTS: Three hundred twenty-six tumor loci were seen. HAP images depicted 309 foci (95%) and PVP images 268 (82%). In seven patients (11%), tumor was visible only on HAP images. During the HAP, tumors were hyperattenuating compared with liver in 26 patients, of mixed attenuation in 26, and hypoattenuating in 14 without correlation with histologic appearance. Portal vein thrombosis was identified in 17 of 21 patients on HAP images; in 12 patients, the thrombosis was diagnosed as malignant with neovascularity within the thrombus or diffuse thrombus enhancement. CONCLUSION: Use of both HAP and PVP contrast-enhanced CT optimizes the evaluation of patients with or at risk for HCC.

AB - PURPOSE: To evaluate the added value of hepatic arterial-dominant phase (HAP) imaging to portal venous-dominant phase (PVP) imaging in patients with hepatocellular carcinoma (HCC) at computed tomography (CT). MATERIALS AND METHODS: Sixty-six patients with proved HCC underwent biphasic contrast- enhanced CT. HAP and PVP images were obtained at 20-50 and 60-100 seconds, respectively. PVP images were evaluated for the number of HCC foci. Then, HAP images were reviewed to determine whether any additional HCCs were seen. RESULTS: Three hundred twenty-six tumor loci were seen. HAP images depicted 309 foci (95%) and PVP images 268 (82%). In seven patients (11%), tumor was visible only on HAP images. During the HAP, tumors were hyperattenuating compared with liver in 26 patients, of mixed attenuation in 26, and hypoattenuating in 14 without correlation with histologic appearance. Portal vein thrombosis was identified in 17 of 21 patients on HAP images; in 12 patients, the thrombosis was diagnosed as malignant with neovascularity within the thrombus or diffuse thrombus enhancement. CONCLUSION: Use of both HAP and PVP contrast-enhanced CT optimizes the evaluation of patients with or at risk for HCC.

KW - Computed tomography (CT), helical

KW - Liver neoplasms

KW - Liver, CT

UR - http://www.scopus.com/inward/record.url?scp=0029988097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029988097&partnerID=8YFLogxK

M3 - Article

C2 - 8668803

AN - SCOPUS:0029988097

VL - 199

SP - 505

EP - 511

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 2

ER -